Voloridge Investment Management
IDYA icon

Voloridge Investment Management’s IDEAYA Biosciences IDYA Stock Holding History

Voloridge Investment Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-283,811
Closed -$5.97M – 1268
2025
Q2 		$5.97M Sell
283,811
-9,764
-3% -$187K 0.02% 715
2025
Q1 		$4.81M Buy
293,575
+6,816
+2% +$145K 0.02% 789
2024
Q4 		$7.37M Buy
286,759
+96,466
+51% +$2.73M 0.03% 665
2024
Q3 		$6.03M Buy
190,293
+24,517
+15% +$930K 0.02% 733
2024
Q2 		$5.82M Buy
+165,776
New +$6.57M 0.02% 714
2023
Q4 		– Sell
-40,753
Closed -$1.1M – 1302
2023
Q3 		$1.1M Sell
40,753
-26,266
-39% -$666K 0.01% 1075
2023
Q2 		$1.57M Buy
+67,019
New +$1.38M 0.01% 1035

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Voloridge Investment Management's IDYA Position: Q3 2025 in Review

Voloridge Investment Management sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 283,811 shares — an estimated $5.97M sold.

Voloridge Investment Management first reported a position in IDYA in Q2 2023 and held it in 7 quarters. The position peaked at $7.37M in Q4 2024. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • Voloridge Investment Management reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 283,811 IDEAYA Biosciences shares in Q3 2025, an estimated $5.97M.
  • Voloridge Investment Management first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 7 quarters.
  • Voloridge Investment Management's IDEAYA Biosciences position peaked at $7.37M in Q4 2024.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Voloridge Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.